Wolkstein Willaim MD is categorized under Physical Medicine, Physician/Surgeon in Shrewsbury, NJ and active since 2010.
Wolkstein Willaim MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Willaim Wolkstein at the company’s single location by writing to 480 Shrewsbury Plaza, Shrewsbury, New Jersey NJ 07702 or by phoning (732) 380-9040. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Wolkstein Willaim MD |
Contact Person: | Willaim Wolkstein |
Address: | 480 Shrewsbury Plaza, Shrewsbury, New Jersey 07702 |
Phone Number: | (732) 380-9040 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Physical Medicine, Physician/Surgeon |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Wolkstein Willaim MD was started in 2010 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Willaim Wolkstein for inquiries that concern Wolkstein Willaim MD by calling the company number (732) 380-9040, as your correspondence is most welcome. Additionally, the physical location of the single location of Wolkstein Willaim MD can be found at the coordinates 40.31341,-74.06637 as well as the street address 480 Shrewsbury Plaza in Shrewsbury, New Jersey 07702.
For its online presence, you may visit Wolkstein Willaim MD’s website at and engage with its social media outlets through on Twitter and on Facebook.